Update on the Inactivation Procedures for the Vaccine Development Prospects of a New Highly Virulent RGNNV Isolate.

Falco, Alberto; Bello-Perez, Melissa; Díaz-Puertas, Rocío; Mold, Matthew; Adamek, Mikolaj

Falco, Alberto; Bello-Perez, Melissa; Díaz-Puertas, Rocío; Mold, Matthew; Adamek, Mikolaj.

Afiliación

Falco A; Institute of Research, Development and Innovation in Healthcare Biotechnology in Elche (IDiBE), Miguel Hernández University, 03202 Elche, Spain.
Bello-Perez M; Institute of Research, Development and Innovation in Healthcare Biotechnology in Elche (IDiBE), Miguel Hernández University, 03202 Elche, Spain.
Díaz-Puertas R; Institute of Research, Development and Innovation in Healthcare Biotechnology in Elche (IDiBE), Miguel Hernández University, 03202 Elche, Spain.
Mold M; The Birchall Centre, Lennard-Jones Laboratories, Keele University, Staffordshire ST5 5BG, UK.
Adamek M; Fish Disease Research Unit, Institute for Parasitology, University of Veterinary Medicine, 30559 Hannover, Germany.

Vaccines (Basel) ; 9(12)2021 Dec 07.

Article en En | MEDLINE | ID: mdl-34960187

Palabras clave

autogenous vaccine; betanodavirus; nervous necrosis virus; viral nervous necrosis; virus inactivation; virus-inactivated vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google